Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5201918
Max Phase: Preclinical
Molecular Formula: C14H10ClN3O2S
Molecular Weight: 319.77
Associated Items:
ID: ALA5201918
Max Phase: Preclinical
Molecular Formula: C14H10ClN3O2S
Molecular Weight: 319.77
Associated Items:
Canonical SMILES: O=c1[nH]cc(CSc2cnc3cc(Cl)ccc3c2)[nH]c1=O
Standard InChI: InChI=1S/C14H10ClN3O2S/c15-9-2-1-8-3-11(6-16-12(8)4-9)21-7-10-5-17-13(19)14(20)18-10/h1-6H,7H2,(H,17,19)(H,18,20)
Standard InChI Key: NBQRJOIQCJRZOK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 319.77 | Molecular Weight (Monoisotopic): 319.0182 | AlogP: 2.56 | #Rotatable Bonds: 3 |
Polar Surface Area: 78.61 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.10 | CX Basic pKa: 2.88 | CX LogP: 1.53 | CX LogD: 1.15 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.57 | Np Likeness Score: -1.21 |
1. Tang H, Jensen K, Houang E, McRobb FM, Bhat S, Svensson M, Bochevarov A, Day T, Dahlgren MK, Bell JA, Frye L, Skene RJ, Lewis JH, Osborne JD, Tierney JP, Gordon JA, Palomero MA, Gallati C, Chapman RSL, Jones DR, Hirst KL, Sephton M, Chauhan A, Sharpe A, Tardia P, Dechaux EA, Taylor A, Waddell RD, Valentine A, Janssens HB, Aziz O, Bloomfield DE, Ladha S, Fraser IJ, Ellard JM.. (2022) Discovery of a Novel Class of d-Amino Acid Oxidase Inhibitors Using the Schrödinger Computational Platform., 65 (9.0): [PMID:35482677] [10.1021/acs.jmedchem.2c00118] |
Source(1):